The Emergence of Early Signs for Autism Spectrum Disorder in Babies at High Risk and Its Relationship with Later Trajectories of Symptom Severity

Poster Presentation
Saturday, May 4, 2019: 11:30 AM-1:30 PM
Room: 710 (Palais des congres de Montreal)
M. Franchini1, L. Zwaigenbaum2, E. Duku3, V. Armstrong4, J. A. Brian5, S. E. Bryson6, N. Garon7, W. Roberts8, C. Roncadin9, L. A. Sacrey10 and I. M. Smith11, (1)Dalhousie University / IWK Health Centre, Halifax, NS, Canada, (2)University of Alberta, Edmonton, AB, Canada, (3)McMaster University, Hamilton, ON, Canada, (4)IWK Health Centre / Dalhousie University, Halifax, NS, Canada, (5)Holland Bloorview Kids Rehabilitation Hospital, Toronto, ON, Canada, (6)Dalhousie University, Halifax, NS, Canada, (7)Mount Allison University, Sackville, NB, Canada, (8)isand, Toronto, ON, Canada, (9)Autism Spectrum Disorder Service, McMaster Children's Hospital - Hamilton Health Sciences, Hamilton, ON, Canada, (10)Autism Research Centre, Edmonton, AB, CANADA, (11)Dalhousie University / IWK Health Centre, Halifax, NS, CANADA

How early signs for autism spectrum disorder (ASD) emerge is currently unknown. The Autism Observation Scale for Infant (AOSI) represents an elegant solution to the prospective observation of the emergence of ASD symptoms in high risk infants. Within this study, we longitudinally assessed infant siblings of children with ASD from 6 to 18 months of age using the AOSI. We followed up the expression of their symptomology using the Autism Diagnostic Observation Schedule (ADOS), collected from 18 months to 5-7 years in the same children. We derived distinctive trajectories of early signs of ASD in infancy, and we observed the conditional probability that those trajectories had on the later trajectories of symptom severity.


The primary goal of the current research was to define, in children at high risk, the relationship between how early signs for ASD emerge and the expression of symptom severity later in life.


The sample was composed of 499 high risk siblings (281 males), of whom 128 received an ASD diagnosis in a blinded assessment at 36 months. We used group-based trajectory models (GBTM) to derive trajectories of early signs for ASD measured at 6, 9, 12, 15 and 18 months of age using the AOSI. Using the same statistical model, we derived symptom severity trajectory groups from the ADOS at 18, 24, 36-42, and 60-84 months. We examined the proportions of children within each trajectory group, and analyzed the conditional probability of switching from a distinctive AOSI trajectory to a later ADOS trajectory.


Analysis revealed three distinctive trajectory groups for early signs measured with the AOSI and three distinctive trajectories for symptom severity measured with the ADOS (Low, Intermediate and Increasing trajectory groups for each). Pairwise comparisons between trajectory groups for quadratic slope and intercept estimates revealed significant differences for all comparisons (all p < .001) for both analyses. As expected, children with an ASD diagnosis were more likely to be in the trajectory groups with the highest scores on both the AOSI and ADOS. Furthermore, children in the Low trajectory group from the AOSI had an 80.2% chance to continue in the Low ADOS trajectory group, 67.5% of the children stayed in the Intermediate trajectory group as measured with both scales and 77.3% remained in the High trajectory group. Importantly, no children from the Low AOSI trajectory group were in the Increasing ADOS trajectory group in later childhood.


Our results confirm substantial heterogeneity in the early emergence of ASD symptomatology in children at high risk for ASD. Moreover, we have shown how the emergence of signs of ASD in infancy is highly predictive of the later patterns of symptomatology. These results have strong clinical implications, supporting the need to screen infants at high risk for ASD repeatedly and to monitor closely how early signs of ASD appear, as this can be highly indicative of the clinical course. The AOSI shows good potential as an early assessment of ASD symptoms.